CFA
SBIO icon

Cahill Financial Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Cahill Financial Advisors’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-500
Closed -$23K – 658
2021
Q3 		$23K Buy
+500
New +$22.9K ﹤0.01% 435

Other funds holding SBIO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MC
Matisse Capital Portland, Oregon $234M AUM 19.72% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Cahill Financial Advisors's SBIO Position: Q4 2021 in Review

Cahill Financial Advisors sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q4 2021, closing a stake of 500 shares — an estimated $23K sold.

Cahill Financial Advisors first reported a position in SBIO in Q3 2021 and held it in 1 quarter. The position peaked at $23K in Q3 2021. 66 funds tracked by Wall St. Rank hold SBIO as of Q4 2021.

  • Cahill Financial Advisors reported no remaining ALPS Medical Breakthroughs ETF position as of Q4 2021 after selling out during the quarter.
  • Cahill Financial Advisors sold 500 ALPS Medical Breakthroughs ETF shares in Q4 2021, an estimated $23K.
  • Cahill Financial Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q3 2021 and held it in 1 quarter.
  • Cahill Financial Advisors's ALPS Medical Breakthroughs ETF position peaked at $23K in Q3 2021.
  • 66 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2021.

Based on Cahill Financial Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.